Urinary and Serologic Markers forInterstitial Cystitis: An Update
Related Experiment Video
Updated: Jul 20, 2026

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
Published on: August 13, 2015
David R Wilkinson1, And Deborah R Erickson
1Division of Urology, University of Kentucky College of Medicine, 800 Rose Street, Room MS 269, Lexington, KY 40536-0298, USA. davidkcw@insightbb.com
Abstract:
This update reviews the published literature from the past 2 years pertaining to urinary and serum markers for interstitial cystitis (IC). Literature on markers described before 2004 also is included when needed to provide background information for the current literature. The markers that have been the focus of the most research in the recent literature are antiproliferative factor, epidermal growth factor, heparin-binding epidermal growth factor-like growth factor, glycosaminoglycans, and bladder nitric oxide. These markers are discussed in consideration of their three different possible roles: 1) as diagnostic markers of IC; 2) distinguishing relevant subsets of IC patients; and 3) measuring disease activity and objectively following treatment response.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection I: Introduction
Urinary Tract Infection II: Pathophysiology
Urine Studies I: Urinalysis